LGALS1 and thyroid gland follicular carcinoma: 62% (39/63) of malignant lesions (papillary and follicular carcinoma) were stained positively with galectin-1 compared to 11% (8/73) of benign lesions (FND and FA), which were stained positively for this marker; the P-value was significantly different (P = 0.0001) shown in Table 3.